Expanding clinical trials for central nervous system cancer treatment in diverse populations.
Official title: A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute
Funded at University of Tx Md Anderson Can Ctr · NIH-11066445 · Data updated 2026-11-12
This study is all about making it easier for patients with brain cancers to join clinical trials at MD Anderson, especially for those from different backgrounds, so they can access the latest treatments and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $86,702 |
| NIH project number | 5R50CA275822-03 |
| Project ID | NIH-11066445 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with central nervous system cancers, particularly those from diverse backgrounds.
✕Less likely to help
Patients with cancers outside the central nervous system or those not seeking clinical trial participation may not benefit from this research.
What this research studies
This research focuses on enhancing the radiation oncology clinical trial program at the University of Texas MD Anderson Cancer Center, specifically targeting patients with central nervous system cancers. The project aims to increase patient enrollment in clinical trials, particularly among diverse populations, by implementing a translational biomarker program and neurocognitive testing. The approach includes collaboration with national cooperative groups to ensure comprehensive care and education for patients. By addressing healthcare disparities, the research seeks to improve access to cutting-edge cancer treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with central nervous system cancers.
How similar studies have gone: Previous research has shown success in increasing clinical trial enrollment among diverse populations, indicating the potential effectiveness of this approach.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Chun, Stephen G — University of Tx Md Anderson Can Ctr
- Study coordinator: Chun, Stephen G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.